Atara Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Thousand Oaks, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Atara Biotherapeutics, Inc. has filed 1,129 SEC EDGAR filings since 10 Apr 2014

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
SC 13G File 005-88393

13G

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2017
Reporting date
09 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2017
Reporting date
09 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

FORM 8-K

Filing date
10 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SC 13G/A

Filing date
07 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
07 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Feb 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88393

SC 13G filing

Filing date
30 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jan 2017
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jan 2017
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jan 2017
Reporting date
05 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Dec 2016
Reporting date
22 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36548

CT ORDER filing

Filing date
19 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .